Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.

Background And Purpose: Clemizole, a histamine H receptor antagonist has a potential therapeutic effect on hepatitis C infection and also potently inhibits TRPC5 ion channels. The aim of the present study was to investigate whether clemizole blocks cardiac K currents and thus affects cardiac repolarization.

Experimental Approach: Whole-cell patch techniques was used to examine the effects of clemizole on hERG channel current, I and K 1.5 channel current in HEK 293 cell expression systems as well as on ventricular action potentials of guinea pig hearts. Isolated hearts from guinea pigs were used to determine the effect on the ECG.

Key Results: Clemizole decreased hERG current by blocking both open and closed states of the channel in a concentration-dependent manner (IC : 0.07 μM). The S631A, S636A, Y652A and F656V hERG mutant channels reduced the inhibitory effect of clemizole (IC : 0.82, 0.89, 1.49 and 2.98 μM, respectively), suggesting that clemizole is a pore blocker of hERG channels. Clemizole also moderately decreased I and human K 1.5 channel current. Moreover, clemizole increased the duration of the ventricular action potential in guinea pig hearts and the QTc interval in isolated perfused hearts from guinea pigs, in a concentration-dependent manner (0.1-1.0 μM).

Conclusion And Implications: Our results provide the first evidence that clemizole potently blocks hERG channels, moderately inhibits cardiac I , delays cardiac repolarization and thereby prolongs QT interval. Thus, caution should be taken when clemizole is used as a TRPC5 channel blocker or for treating hepatitis C infection.